Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,370,435
-$53,924 QoQ
Shares Held
13,271
-5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,916
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Octavia Wealth Advisors, LLC holds $7,437,513 across 8 Drug Manufacturers - General names. JNJ ranks #1 (45.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
13,271 | $3,370,435 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,648 | $982,768 | |
| 3 | LLY |
ELI LILLY & Co
|
772 | $925,960 | |
| 4 | PFE |
Pfizer Inc
|
29,381 | $707,494 | |
| 5 | ABBV |
AbbVie Inc.
|
1,934 | $486,671 | |
| 6 | AMGN |
Amgen Inc
|
1,195 | $432,733 | |
| 7 | NVO |
Novo Nordisk A S
|
6,751 | $323,642 | |
| 8 | NVS |
Novartis AG
|
1,326 | $207,810 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,370,435 | 13,271 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,424,359 | 14,009 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,960,419 | 14,305 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,686,921 | 14,491 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,163,092 | 14,161 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,366,536 | 14,270 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,008,048 | 13,885 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,177,762 | 13,438 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,517,725 | 10,384 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,642,803 | 10,385 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,757,525 | 11,213 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,796,887 | 11,537 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,829,823 | 11,055 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,632,305 | 10,531 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,884,678 | 10,669 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,758,080 | 10,762 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,919,948 | 10,816 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,132,254 | 12,031 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,057,801 | 12,029 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,776,015 | 10,997 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,835,038 | 11,139 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,809,657 | 11,011 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,520,133 | 9,659 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||